✦ LIBER ✦

Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada

✍ Scribed by Gerth, William C; Betschel, Stephen D; Zbrozek, Arthur S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Implications to payers of switch from ho

✍ Gerth, William C; Betschel, Stephen D; Zbrozek, Arthur S 📂 Article 📅 2014 🏛 BC Decker 🌐 English ⚖ 85 KB

Efficacy and safety of home-based subcut

✍ M. Borte; E. Bernatowska; H. D. Ochs; C. M. Roifman; the Vivaglobin Study Group 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

Immunoglobulin Dosage and Switch from In

✍ Sylvain Thépot; Marion Malphettes; Anaëlle Gardeur; Lionel Galicier; Bouchra Asl 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 175 KB

Efficacy and Safety of IgPro20, a 20% Im

✍ Stephen Jolles; Victor Cristea; Volker Wahn; Marianne Debré; Hilary Longhurst; O 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 61 KB